NCT05841212

Brief Summary

Attention Deficit Hyperactive Disorder (ADHD) is linked to three main symptoms: hyperactivity, inattention and impulsivity. It is increasingly being acknowledged that these symptoms have a wide-reaching impact on a person's life. Adolescents with ADHD are six times more likely to be excluded from school, have difficulties turn taking, express anger more often, have poorer emotion regulation and self-report a lower quality of life. In adulthood, people with ADHD are more likely to develop mental health difficulties, and to experience unemployment, divorce and be imprisoned. It is thought that emotion regulation and poor social skills are key factors leading to increases in mental health difficulties and poorer long term social outcomes. This pilot trial will look at whether an intervention which aims to increase emotion regulation and social functioning is acceptable and feasible. The intervention will be an adapted Dialectical Behaviour Therapy (DBT) skills group with an ADHD focus. DBT is an approach that aims to provide skills to assist an individual identify what they are feeling and change what they do in response to that feeling. For example, if an individual feels anger and the urge to be aggressive, DBT helps them to problem solve and find a more effective way of responding to their anger. Also, if an individual wants to communicate a relational need to others DBT helps them think about the most effective actions they can take to achieve this outcome. The intervention will be developed in collaboration with adolescents with ADHD. The intervention will then be delivered at the child and adolescent outpatient clinic site they received their diagnosis from. All participants will have a confirmed diagnosis of ADHD. Pre and post measures will be collected and reported on. The research team hope to commence recruitment in July 2023 and finish all data collection by 31st March 2024.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Feb 2025Sep 2026

First Submitted

Initial submission to the registry

March 16, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 3, 2023

Completed
1.8 years until next milestone

Study Start

First participant enrolled

February 27, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

March 6, 2025

Status Verified

March 1, 2025

Enrollment Period

1.6 years

First QC Date

March 16, 2023

Last Update Submit

March 4, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • 25 participants with ADHD will be recruited from CAMHS services.

    To assess whether the intervention is feasible in terms of recruitment, for adolescents with ADHD.

    Within12-months

  • 60% of participants or more will attend all group sessions.

    To assess whether the intervention is feasible in terms of retention, for adolescents with ADHD.

    Within12-months

  • 60% or more of participants will complete a follow up measures.

    To assess whether the intervention is feasible in terms of retention, for adolescents with ADHD.

    Within12-months

  • Individual participant attendance rate will be greater than 50%.

    To assess whether the intervention is feasible in terms of retention, for adolescents with ADHD.

    Within12-months

  • 66% of participants or more will report above neutral satisfaction ratings on weekly questionnaire

    To assess whether participants will find both the intervention and assessment methods acceptable.

    Within 12 months

  • 66% of participants or more from the focus group will report above neutral satisfaction.

    To assess whether participants will find both the intervention and assessment methods acceptable, we will conduct a focus group and use thematic analysis to ascertain the satisfaction rating.

    Within 12 months

Secondary Outcomes (4)

  • At post-treatment compared to baseline participants will report improved levels of emotion regulation

    Within 12 months

  • At post-treatment compared to baseline participants will report a reduction in ADHD symptoms.

    Within 12 months

  • At post treatment compared to baseline participants will report improved social skills and functioning.

    Within 12 months

  • At post treatment compared to baseline participants will report improved social skills and functioning.

    Within 12 months

Study Arms (1)

DBT for ADHD

OTHER

The intervention will consist of a DBT skills group. Its name, length, style and content will be guided by the viewpoints shared in the intervention planning focus group/ individual interviews, and taken into consideration alongside a clinical rational and the evidence-based content. It will include skills from all four of the DBT modules: Mindfulness, Distress Tolerance, emotion regulation and interpersonal effectiveness. There will be an emphasis on the skills relevant to ADHD symptoms plus a core psychoeducational component on ADHD symptoms. The intervention will be adapted from Rathus and Miller's (2014) DBT for adolescents (DBT-A) manual. The group format will be didactic teaching with group discussion and experiential exercises to aid learning.

Other: DBT for ADHD

Interventions

See information included in arm/group description.

DBT for ADHD

Eligibility Criteria

Age13 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosis of Attention Deficit Hyperactive disorder (using either DSM 5, DSM-IV, or ICD-10 - F90)
  • Age 13-16 years
  • Likely to benefit from DBT skills and can safely access/ engage in group interventions as assessed by clinical team \[for intervention part\]

You may not qualify if:

  • A low enough proficiency in written and spoken English that they would be unable to engage in the content of the group.
  • Have not recently changed their medication in the last 2 weeks\*, commenced a new medication in the last 2 weeks\* or are receiving additional concurrent psychological intervention. (\*calculated from the start of the intervention).
  • The identified participant has recently taken part in another research trial and are at risk of research burden.
  • Pose a risk to others in the group

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South London and Maudsley Foundation Trust

London, United Kingdom

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2023

First Posted

May 3, 2023

Study Start

February 27, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

March 6, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data available to other researchers.

Locations